• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

构建癌症进展模型:器官和肿瘤特异性基质的影响。

Framing cancer progression: influence of the organ- and tumour-specific matrisome.

机构信息

Biotech Research and Innovation Centre (BRIC), University of Copenhagen (UCPH), Denmark.

出版信息

FEBS J. 2020 Apr;287(8):1454-1477. doi: 10.1111/febs.15223. Epub 2020 Feb 6.

DOI:10.1111/febs.15223
PMID:31972068
Abstract

The extracellular matrix (ECM) plays a crucial role in regulating organ homeostasis. It provides mechanical and biochemical cues directing cellular behaviour and, therefore, has control over the progression of diseases such as cancer. Recent efforts have greatly enhanced our knowledge of the protein composition of the ECM and its regulators, the so-called matrisome, in healthy and cancerous tissues; yet, an overview of the common signatures and organ-specific ECM in cancer is missing. Here, we address this by taking a detailed approach to review why cancer grows in certain organs, and focus on the influence of the matrisome at primary and metastatic tumour sites. Our in-depth and comprehensive review of the current literature and general understanding identifies important commonalities and distinctions, providing insight into the biology of metastasis, which could pave the way to improve future diagnostics and therapies.

摘要

细胞外基质(ECM)在调节器官稳态方面起着至关重要的作用。它提供了指导细胞行为的机械和生化线索,因此控制着癌症等疾病的发展。最近的研究极大地提高了我们对 ECM 及其调节剂(所谓的基质组)在健康组织和癌变组织中的蛋白组成的认识;然而,对于癌症中常见的特征和器官特异性 ECM,我们还缺乏一个全面的概述。在这里,我们通过详细的方法来解决这个问题,即探讨为什么癌症会在某些器官中生长,并关注基质组在原发性和转移性肿瘤部位的影响。我们对当前文献和一般认识的深入而全面的回顾,确定了重要的共性和区别,深入了解转移的生物学,为改善未来的诊断和治疗方法铺平了道路。

相似文献

1
Framing cancer progression: influence of the organ- and tumour-specific matrisome.构建癌症进展模型:器官和肿瘤特异性基质的影响。
FEBS J. 2020 Apr;287(8):1454-1477. doi: 10.1111/febs.15223. Epub 2020 Feb 6.
2
Dynamic matrisome: ECM remodeling factors licensing cancer progression and metastasis.动态基质体:ECM 重塑因子授权癌症进展和转移。
Biochim Biophys Acta Rev Cancer. 2018 Dec;1870(2):207-228. doi: 10.1016/j.bbcan.2018.09.002. Epub 2018 Oct 12.
3
The interplay between extracellular matrix remodelling and kinase signalling in cancer progression and metastasis.细胞外基质重塑与激酶信号在癌症进展和转移中的相互作用。
Cell Adh Migr. 2018;12(6):529-537. doi: 10.1080/19336918.2017.1405208. Epub 2017 Dec 29.
4
Matricellular proteins: priming the tumour microenvironment for cancer development and metastasis.基质细胞蛋白:为肿瘤微环境的癌症发生和转移做好准备。
Br J Cancer. 2013 Mar 5;108(4):755-61. doi: 10.1038/bjc.2012.592. Epub 2013 Jan 15.
5
The alternative matrisome: Alternative splicing of ECM proteins in development, homeostasis and tumor progression.替代性基质:细胞外基质蛋白在发育、稳态和肿瘤进展中的可变剪接。
Matrix Biol. 2022 Aug;111:26-52. doi: 10.1016/j.matbio.2022.05.003. Epub 2022 May 7.
6
Charting the unexplored extracellular matrix in cancer.绘制癌症中未探索的细胞外基质图谱。
Int J Exp Pathol. 2018 Apr;99(2):58-76. doi: 10.1111/iep.12269. Epub 2018 Apr 19.
7
Concepts of extracellular matrix remodelling in tumour progression and metastasis.肿瘤进展和转移中外细胞基质重塑的概念。
Nat Commun. 2020 Oct 9;11(1):5120. doi: 10.1038/s41467-020-18794-x.
8
The extracellular matrix in tumor progression and metastasis.肿瘤进展和转移中的细胞外基质。
Clin Exp Metastasis. 2019 Jun;36(3):171-198. doi: 10.1007/s10585-019-09966-1. Epub 2019 Apr 11.
9
The cancer matrisome: From comprehensive characterization to biomarker discovery.癌症基质组学:从全面刻画到生物标志物发现。
Semin Cell Dev Biol. 2019 May;89:157-166. doi: 10.1016/j.semcdb.2018.06.005. Epub 2018 Jul 13.
10
The matrix environmental and cell mechanical properties regulate cell migration and contribute to the invasive phenotype of cancer cells.基质的环境和细胞力学特性调节细胞迁移,并有助于癌细胞的侵袭表型。
Rep Prog Phys. 2019 Jun;82(6):064602. doi: 10.1088/1361-6633/ab1628. Epub 2019 Apr 4.

引用本文的文献

1
Alternative Splicing of FBLN2 Generates a Prometastatic Extracellular Matrix in Gastrointestinal Cancers by Determining N-Glycosylation of Fibulin 2.FBLN2的可变剪接通过决定纤连蛋白2的N-糖基化在胃肠道癌症中产生促转移细胞外基质。
Genes Cells. 2025 May;30(3):e70027. doi: 10.1111/gtc.70027.
2
Deciphering the Matrisome: Extracellular Matrix Remodeling in Liver Cirrhosis and Hepatocellular Carcinoma.解析基质组:肝硬化和肝细胞癌中的细胞外基质重塑
Cureus. 2025 Apr 13;17(4):e82171. doi: 10.7759/cureus.82171. eCollection 2025 Apr.
3
Multiple aspects of matrix stiffness in cancer progression.
癌症进展中基质刚度的多个方面。
Front Oncol. 2024 Jul 2;14:1406644. doi: 10.3389/fonc.2024.1406644. eCollection 2024.
4
A prognostic matrix gene expression signature defines functional glioblastoma phenotypes and niches.一种预后矩阵基因表达特征可定义功能性胶质母细胞瘤表型和生态位。
Res Sq. 2024 Jun 21:rs.3.rs-4541464. doi: 10.21203/rs.3.rs-4541464/v1.
5
Clinicopathological significance of microsatellite instability and immune escape mechanism in patients with gastric solid-type poorly differentiated adenocarcinoma.胃实体型低分化腺癌中微卫星不稳定性与免疫逃逸机制的临床病理意义。
Gastric Cancer. 2024 May;27(3):484-494. doi: 10.1007/s10120-024-01474-w. Epub 2024 Mar 5.
6
Extracellular matrix in cancer progression and therapy.癌症进展与治疗中的细胞外基质
Med Rev (2021). 2022 Apr 26;2(2):125-139. doi: 10.1515/mr-2021-0028. eCollection 2022 Apr.
7
Trends in Photopolymerizable Bioinks for 3D Bioprinting of Tumor Models.用于肿瘤模型3D生物打印的可光聚合生物墨水的研究趋势
JACS Au. 2023 Aug 11;3(8):2086-2106. doi: 10.1021/jacsau.3c00281. eCollection 2023 Aug 28.
8
Dysregulated Signalling Pathways Driving Anticancer Drug Resistance.调控异常的信号通路导致抗癌药物耐药性。
Int J Mol Sci. 2023 Jul 30;24(15):12222. doi: 10.3390/ijms241512222.
9
Fibroblast-derived matrix models desmoplastic properties and forms a prognostic signature in cancer progression.成纤维细胞衍生的基质模型具有促结缔组织增生特性,并在癌症进展中形成预后特征。
Front Immunol. 2023 Jul 18;14:1154528. doi: 10.3389/fimmu.2023.1154528. eCollection 2023.
10
The Extracellular Matrix: Its Composition, Function, Remodeling, and Role in Tumorigenesis.细胞外基质:其组成、功能、重塑及其在肿瘤发生中的作用
Biomimetics (Basel). 2023 Apr 5;8(2):146. doi: 10.3390/biomimetics8020146.